Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that France’s National Agency for Medicines and Health Products Safety (ANSM) has approved an updated national ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback